NCT05219799RecruitingEarly phase 1
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
Source: ClinicalTrials.gov · Last updated 28 Jul 2026
Brief summary (registry, in English)
The purpose of this project is to examine key mechanisms contributing to sex-differences in hypoxic vasodilation and the impact of obesity, with particular emphasis on the sympathetic nervous system.
- Status (registry)
- Recruiting
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- First submitted
- 21 Jan 2022
- Start date
- Mar 2023
- Primary completion date
- Jul 2027
- Lead sponsor
- University of Missouri-Columbia
- Diseases
- Obesity
- NCT number
- NCT05219799
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 72
- From Mar 2023 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prescription medications, Sensitivity to lidocaine
Other illness
- Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy
- Nerve/neurologic disease
- Cardiovascular, hepatic, renal, respiratory disease
- Diabetes, Polycystic ovarian syndrome
Other
- Pregnancy, breastfeeding
- Diagnosed sleep apnea or AHI \>10 events/hr
- Current smoking/Nicotine use
- Blood pressure ≥140/90 mmHg
- Communication barriers
Who the study is looking for
- BMI \>18 kg/m2
Age in the registry: 18 years to 45 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Missouri Coordinator of this site? Confirm its status | Columbia | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.